Skip to main content
Dr. Kefas and Dr. Dave examine a young girl with noma who underwent life-changing reconstructive surgery.
Dr Kefas and Dr Dave examine a young girl with noma who underwent life-changing reconstructive surgery. Nigeria, October 2023.
© Alexandre Marcou/MSF

Four diseases you’ve probably never heard of

Dr Kefas and Dr Dave examine a young girl with noma who underwent life-changing reconstructive surgery. Nigeria, October 2023.
© Alexandre Marcou/MSF
Ebola disease in DRC: find out how we're responding
Learn more

In the most remote places in the world, people are daily battling diseases that many people may never have heard of. Called neglected tropical diseases, the World Health Organization (WHO) officially recognises 20 such conditions. They’re called neglected diseases because diagnostics and treatments for them are overlooked by governments, pharmaceutical companies, and philanthropists.

In Médecins Sans Frontières (MSF) projects, from South Sudan to Nigeria, and Ethiopia to Honduras, these diseases are hard to neglect. Our teams see how they are distressing, disfiguring, and stigmatising for people who are infected. Here are four neglected tropical diseases we see in communities we serve, and what can be done to prevent, control, eliminate, and eradicate them.

Funke Adagboyega, MSF counsellor from the Mental health department, talks to Aisha L., a 45-year-old survivor from Yobe state, before her surgery. Aisha L. is proud to be an example to other people suffering noma. ‘Anyone with noma who sees me would be willing to come to the hospital and get treated’. May 5, 2023.
Funke Adagboyega, MSF counsellor from the mental health department, talks to Aisha L., a 45-year-old noma survivor from Yobe state, before her surgery. Nigeria, 5 May  2023.
© Fabrice Caterini/Inediz

1. Noma

In the extreme northwest of Nigeria, an MSF team works with the Ministry of Health at the Sokoto noma hospital - a place where noma patients can receive treatment, reconstructive surgery, and mental health support away from stigma. Noma is a disease that disfigures the people it infects, and it can be fatal for 90 per cent of children who contract it.

Noma begins as ulcers in the mouth that quickly turn gangrenous, eating away at facial tissue. If antibiotics are used early enough, noma is completely treatable. That’s why our project also focuses on community outreach activities, as awareness and prevention measures.

Noma is the newest neglected tropical disease recognised by WHO. It was added to the official list in December 2023 after years of advocacy from noma survivors and people who support them. While we hope that the addition of noma to the list will mean more investment into understanding, preventing, and treating the disease, new developments are yet to be seen. Insights into noma will be a game changer for the estimated 140,000 people who are infected every year. 

MSF mobile clinic team working in Old Fangak Country. Every two weeks, they travel by boat throughout the most isolated villages, where communities have no access to healthcare. 
The Sudd region is one of the world's largest wetlands. Its inhabitants have adapted their lives to the natural ebb and flow of seasonal floods, which depend on rainfall patterns and water levels in upstream Lake Victoria, Uganda.
However in recent years extreme flooding has engulfed up to two-thirds of South Sudan.
In Old Fangak, only mud dykes protect the town's thousands of inhabitants from submersion.
Old Fangak, Jonglei state, South Sudan, July 2024.
An MSF mobile clinic team working in Old Fangak travel by boat throughout the most isolated villages every two weeks, where communities have no access to healthcare. Old Fangak, Jonglei state, South Sudan, July 2024.
© Simon Rolin/MSF

2. Schistosomiasis

Schistosomiasis gets its common name, snail fever, because it is caused by a parasite in snails. These snails live in freshwater, making people who live near lakes and rivers susceptible to the disease. Schistosomiasis is found in tropical and subtropical countries around the world, but in South Sudan, the highest prevalence of the disease is in Jonglei state, where MSF runs a hospital in the remote town of Old Fangak.

Old Fangak is subject to frequent and extreme flooding, and our teams suspect that many women and girls there are suffering from an advanced form of schistosomiasis, female genital schistosomiasis. Many of the interventions for the disease are preventive, and a vaccine is even in the early stages of development. But this is little comfort for people who have already been infected. People with female genital schistosomiasis have debilitating inflammation, and the disease can turn into cancer. In Old Fangak, we are working to ensure women and girls are accurately diagnosed and provided with the best treatment. 

MSF medical staff are examining Mekuanent, a kala azar patient during the morning rounds at MSF’s Abdurafi health center specializing in treatment of Kala-azar and snakebite.
Among the young male population the prevalence of HIV infection is relatively high. That creates a unique situation with between 20 and 40% of kala azar patients HIV co-infected. This combination of two diseases, both severely immune suppressive, is almost impossible to cure.
MSF medical staff examine Mekuanent, a kala azar patient, during the morning rounds at MSF’s Abdurafi health centre specialising in the treatment of kala azar and snakebite. Ethiopia, June 2023.
© Amanuel Sileshi/MSF

3. Visceral leishmaniasis

Visceral leishmaniasis is also called kala azar (‘black fever’ in Hindi), and is most commonly found in Brazil, across East Africa, and in India. We’ve been treating visceral leishmaniasis for decades in Ethiopia. People infected with this neglected tropical disease will have their tissue attacked by a parasite, which is transmitted through the bites of sandflies. Initial mild symptoms – often mistaken for other diseases – develop into a prolonged fever, enlarged spleen, anaemia, and substantial weight loss. Without treatment, it can quickly become fatal.

Thankfully, there is a cure. A combination of two drugs injected daily for 17 days can save an infected person’s life. Timely diagnosis and access to the drugs remain a challenge in the treatment of visceral leishmaniasis in East Africa, but continued advocacy has made progress in the last few years.

A MSF lab technician, who travels with a mobile laboratory, including microscopes and centrifuges, tests a blood sample for sleeping sickness. MSF mobile medical teams are spending 8 months travelling through DRC and aim to test and treat 42,000 people for sleeping sickness.
A lab technician, who travels with a mobile laboratory, including microscopes and centrifuges, tests a blood sample for sleeping sickness. Democratic Republic of Congo, August 2015.
© Philipp Frisch/MSF

4. Sleeping sickness

In the last 25 years, there has been a 97 per cent reduction in the number of people suffering from sleeping sickness, also known as human African trypanosomiasis. This neglected disease, caused by parasites from tsetse fly bites, was eliminated in Equatorial Guinea, Côte d’Ivoire, Benin, Togo, Uganda, and Chad in 2024. Now, Guinea also joins the list of countries that have eliminated sleeping sickness.

The parasites that cause sleeping sickness attack the brain and spinal cord, leaving infected people to eventually fall into a coma. Without treatment, it’s fatal. Before the 1970s, the only available treatment, derived from arsenic, killed one in 20 people. Today, thanks to the work of our partner organisation Drugs for Neglected Diseases initiative, there is a simple and safe oral treatment.